<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21786">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02016612</url>
  </required_header>
  <id_info>
    <org_study_id>007</org_study_id>
    <nct_id>NCT02016612</nct_id>
  </id_info>
  <brief_title>Seri Surgical Scaffold Support of the Lower Pole of the Breast</brief_title>
  <acronym>Seri Support</acronym>
  <official_title>Seri Surgical Scaffold (TM) Support of the Lower Pole of the Breasts in Augmentation Mastopexy or Breast Reduction Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bengtson Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allergan Medical</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Bengtson Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Will the use of an FDA approved highly purified silk scaffold; Seri Surgical Scaffold help
      shape and hold the breast up on the chest preventing re-stretching and bottoming out of the
      breast in breast reduction or augmentation-mastopexy patients? The amount of stretch will be
      measured manually as well as percent of breast tissue measured with the Canfield Vectra 3-D
      Imaging system reporting the amount of breast tissue above and below the nipple level.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients having augmentation mastopexy or breast reduction will be informed about Seri
      Scaffold and allowed to have Seri support included in their surgery or not.  If the choose
      the scaffold will be placed under the skin in the lower pole of the breast as an internal
      hammock to help take weight off of the breast and potentially help prevent future stretch of
      the lower pole.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2013</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Nipple to Fold Measurement on Stretch</measure>
    <time_frame>1 year post op</time_frame>
    <safety_issue>No</safety_issue>
    <description>The Niplle to fold will be measured manually over time to 1 year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent breast tissue above nipple</measure>
    <time_frame>1 year post op</time_frame>
    <safety_issue>No</safety_issue>
    <description>The percentage of breast tissue above and below the horizontal plane of the nipple over time</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Recurrent Ptosis of the Breast</condition>
  <arm_group>
    <arm_group_label>Reduction, Mastopexy No Implant, No Seri</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing reduction or mastopexy but no implant is used and no Seri support</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mastopexy, Implant  no Seri Scaffold</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mastopexy with implant, No Seri support is used</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breast Reduction with Seri Support</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergoing breast reduction with the use of Seri support</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Augmentation Mastopexy, Implant and Seri</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Augmentation Mastopexy patients where Seri Scaffold is placed</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Seri Surgical Scaffold</intervention_name>
    <description>An FDA approved Bioabsorbable mesh Seri Surgical Scaffold will be utilized in the study as an internal hammock mesh support of the breast.</description>
    <arm_group_label>Reduction, Mastopexy No Implant, No Seri</arm_group_label>
    <arm_group_label>Mastopexy, Implant  no Seri Scaffold</arm_group_label>
    <arm_group_label>Breast Reduction with Seri Support</arm_group_label>
    <arm_group_label>Augmentation Mastopexy, Implant and Seri</arm_group_label>
    <other_name>Seri</other_name>
    <other_name>Seri Scaffold</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age =&gt;18 years

          -  requesting procedure

          -  No active cancer or infection

        Exclusion Criteria:

          -  Known allergy to silk

          -  Pregnant or lactating
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bradley P Bengtson, MD</last_name>
    <phone>6165888880</phone>
    <email>drb@bengtsoncenter.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cheryl Maier</last_name>
    <phone>6165888880</phone>
    <email>cheryl@bengtsoncenter.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bengtson Center for Aesthetics and Plastic Surgery</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bradley Bengtson</last_name>
      <phone>616-588-8880</phone>
      <email>drb@bengtsoncenter.com</email>
    </contact>
    <investigator>
      <last_name>Bradley P Bengtson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bengtson Center for Aesthetics and Plastic Surgery</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bradley P Bengtson, MD</last_name>
      <phone>616-588-8880</phone>
      <email>drb@bengtsoncenter.com</email>
    </contact>
    <contact_backup>
      <last_name>Cheryl Maier</last_name>
      <phone>6165888880</phone>
      <email>cheryl@bengtsoncenter.com</email>
    </contact_backup>
    <investigator>
      <last_name>Bradley P Bengtson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 19, 2013</lastchanged_date>
  <firstreceived_date>December 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bengtson Center</investigator_affiliation>
    <investigator_full_name>Bradley Bengtson, M.D.</investigator_full_name>
    <investigator_title>Bradley P Bengtson, MD FACS</investigator_title>
  </responsible_party>
  <keyword>Recurrent</keyword>
  <keyword>Ptosis</keyword>
  <keyword>Reduction</keyword>
  <keyword>Mammoplasty</keyword>
  <keyword>Mastopexy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
